Labrix Revenue and Competitors

Labrix was founded by clinicians Jay H. Mead, MD, FASCP and Erin T. Lommen, ND with the goal of raising the bar on quality hormone testing. With Dr. Mead’s 25 years in laboratory medicine, plus the doctors combined 40 plus years in clinical practice, Labrix founders were well positioned to achieve their goal. In a few short years, Labrix became recognized for setting a new standard for saliva testing in accuracy, reliability and turnaround times. Labrix introduced neurotransmitter testing in 2012, meeting the need for non-invasive solutions for practitioners who wanted a more comprehensive view of the body’s functional neuroendocrine status. In 2016, Labrix was acquired by Doctor’s Data Inc. The combined strengths of both companies, including clinical education and support, and a more comprehensive test menu are now available to providers worldwide. Doctor's Data, Inc. has provided innovative specialty testing to healthcare practitioners around the world from our advanced, CLIA-licensed clinical laboratory since 1972. A specialist and pioneer in essential and toxic elemental testing, the laboratory provides a wide array of functional testing to aid in decision making and better patient outcomes. Choose DDI to help you assess and treat heavy metal burden, nutritional deficiencies, gastrointestinal function, cardiovascular risk, hormonal status, liver and metabolic abnormalities, and more.